ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print

Coronavirus testing for US workplaces offered by Konica Minolta

Biotech unit to field clients directly as safety concerns mount

Ambry Genetics has the capacity to conduct 2,000 polymerase chain reaction tests daily. (Photo courtesy of the company)

TOKYO -- Konica Minolta plans to offer a coronavirus testing service for U.S. businesses in fields such as logistics and infrastructure that look to prevent outbreaks at warehouses and other sites where staff continue to work despite lockdowns.

California-based subsidiary Ambry Genetics will perform the service, becoming one of the first testing providers in the U.S. to field requests from commercial customers.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more